Literature DB >> 10607251

Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis.

N Hayashi1, E Mita.   

Abstract

Enhanced Fas system-mediated hepatocyte apoptosis is observed in hepatitis C virus (HCV)- and hepatitis B virus (HBV)-associated chronic liver diseases. In these forms of viral hepatitis, liver-infiltrating lymphocytes that recognize the viral antigen on hepatocytes become activated and express cytolytic Fas ligand (FasL) molecules. In contrast, hepatocytes exhibit enhanced Fas expression and become susceptible to FasL-mediated death. Augmentation of the Fas system has also been observed in other liver diseases and biliary disorders. Moreover, the Fas system is involved in removing aged hepatocytes. Thus, Fas-mediated apoptosis plays an important role in several liver diseases and in maintaining normal liver homeostasis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10607251     DOI: 10.1046/j.1365-2893.1999.00175.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  22 in total

1.  Apoptosis in chronic viral hepatitis parallels histological activity: an immunohistochemical investigation using anti-activated caspase-3 and M30 cytodeath antibody.

Authors:  Jo L McPartland; Muna Ali Guzail; Charles H Kendall; James Howard Pringle
Journal:  Int J Exp Pathol       Date:  2005-02       Impact factor: 1.925

2.  Soluble TRAIL levels decreased in chronic hepatitis C treatment with pegylated interferon α plus ribavirin: association with viral responses.

Authors:  Derya Seyman; Arzu Didem Yalcin; Nefise Oztoprak; Gizem Esra Genc; Nevgun Sepin Ozen; Filiz Kizilates; Hande Berk; Saadet Gumuslu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 3.  Opioids and HIV/HCV infection.

Authors:  Xu Wang; Ting Zhang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-14       Impact factor: 4.147

Review 4.  Evolving concepts of apoptosis in idiopathic pulmonary fibrosis.

Authors:  Victor J Thannickal; Jeffrey C Horowitz
Journal:  Proc Am Thorac Soc       Date:  2006-06

5.  Caspase Inhibition Reduces Hepatic Tissue Factor-Driven Coagulation In Vitro and In Vivo.

Authors:  Anna K Kopec; Alfred P Spada; Patricia C Contreras; Nigel Mackman; James P Luyendyk
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

6.  Salvianolic acid A attenuates TNF-α- and D-GalN-induced ER stress-mediated and mitochondrial-dependent apoptosis by modulating Bax/Bcl-2 ratio and calcium release in hepatocyte LO2 cells.

Authors:  Xiaojing Yan; Zequn Jiang; Lei Bi; Ye Yang; Weiping Chen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-05-06       Impact factor: 3.000

7.  Upregulation of lymphotoxin beta expression in liver progenitor (oval) cells in chronic hepatitis C.

Authors:  K N Lowes; E J Croager; L J Abraham; J K Olynyk; G C T Yeoh
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

8.  X-ray induced L02 cells damage rescued by new anti-oxidant NADH.

Authors:  Fa-Quan Liu; Ji-Ren Zhang
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

Review 9.  Caspase inhibitors for the treatment of hepatitis C.

Authors:  Howard C Masuoka; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Clin Liver Dis       Date:  2009-08       Impact factor: 6.126

10.  Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals.

Authors:  Christina M Martin; Jeffrey A Welge; Norah J Shire; Mohamed T Shata; Kenneth E Sherman; Jason T Blackard
Journal:  Cytokine       Date:  2009-07-21       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.